Literature DB >> 6102287

Capnocytophaga sepsis: a newly recognised clinical entity in granulocytopenic patients.

S W Forlenza, M G Newman, A I Lipsey, S E Siegel, U Blachman.   

Abstract

10 episodes of Capnocytophaga sepsis occurred in 6 patients with granulocytopenia, malignancy, and oral mucosal ulcerations. Capnyocytophaga is a newly described genus of gliding gram-negative bacilli which is physiologically and genetically identical to Bacteroides ochraceus and biogroup DF-1 of the United States Center for Disease Control and is commonly responsible for periodontal infections.

Entities:  

Mesh：

Year:  1980        PMID： 6102287     DOI： 10.1016/s0140-6736(80)91057-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  31 in total

1.  Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.

Authors:  D L Roscoe; S J Zemcov; D Thornber; R Wise; A M Clarke
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Characterization of CSP-1, a novel extended-spectrum beta-lactamase produced by a clinical isolate of Capnocytophaga sputigena.

Authors:  Hélène Guillon; François Eb; Hedi Mammeri
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

3.  In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.

Authors:  J L Rummens; B Gordts; H W Van Landuyt
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

4.  Eight cases of Capnocytophaga infections in Denmark.

Authors:  A Bremmelgaard; J E Kristiansen; C Pers; W Frederiksen; B Korner; S S Schrøder
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267

5.  Sensitivity of Capnocytophaga species to bactericidal properties of human serum.

Authors:  M E Wilson; R Burstein; J T Jonak-Urbanczyk; R J Genco
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

6.  Rapid identification of Capnocytophaga isolated from septicemic patients.

Authors:  J E Kristiansen; A Bremmelgaard; H E Busk; O Heltberg; W Frederiksen; T Justesen
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

7.  Antimicrobial susceptibility of Capnocytophaga.

Authors:  S W Forlenza; M G Newman; A L Horikoshi; U Blachman
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

8.  Bactericidal activities of synthetic human leukocyte cathepsin G-derived antibiotic peptides and congeners against Actinobacillus actinomycetemcomitans and Capnocytophaga sputigena.

Authors:  K T Miyasaki; A L Bodeau; J Pohl; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 9.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Septic arthritis involving Capnocytophaga ochracea.

Authors:  R E Winn; W F Chase; P W Lauderdale; F K McCleskey
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.